还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

                               
登录/注册后可看大图

0 u8 P% _1 |# z3 e请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  
3 \+ x& B& e$ Y  O! ^

Sub-category:
0 J( H+ @, c+ d4 A. |7 [Molecular Targets
. |) f4 b- b8 v; d% l
. P0 c: F1 w* T# s
, @6 }& ]  K3 g4 T( P; h! bCategory:
Tumor Biology


Meeting:
2011 ASCO Annual Meeting

( W: m4 E7 s3 n$ N) x+ G1 S6 I
Session Type and Session Title:
Poster Discussion Session, Tumor Biology
3 |7 Z  W7 p! C4 j
2 x# o  g* y7 D5 w5 O" {
6 X  _+ `; |0 N, r8 ^Abstract No:
- @: _7 W- u5 J1 }$ l/ A; a10517
  h% x4 U, |3 g* I2 n- @
2 B- N: X7 g' J2 @$ H
$ ^6 p6 T( s$ Q: L3 W" t) E; a* TCitation:
( Z& ^4 h7 l! L0 c. gJ Clin Oncol 29: 2011 (suppl; abstr 10517)
# G# p; b7 g  N6 \% {

* e+ _8 B) ^" R# NAuthor(s):
J. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China

6 N4 }9 `6 {) u# v

9 N8 J2 p' L' U$ t7 }Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.
- ^/ K- i$ y/ ~" K& a2 ^
Abstract Disclosures
# N5 \' {  j' p" F8 s
& p* {% _# D9 u  l2 u) `+ ^Abstract:

. W; S6 |" S% G1 l4 Q# S0 E* b
9 E5 J+ G7 b3 A5 E( l; yBackground: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.

6 D# s1 W9 q" g/ a4 S, J1 @
: R0 k1 m! }; B4 b% j1 n

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

                               
登录/注册后可看大图

$ h0 ?2 i! r; W1 q8 c7 X没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

$ Q/ Y; z* z! w5 ~( `* f化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

                               
登录/注册后可看大图

易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
ALK一个指标医院要900多 ...

1 t6 ~1 W5 t7 L" i4 f: T5 S* M平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？
+ z, Y) S+ I' \0 B: y( n/ \
现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊